Comparative effectiveness and safety of analgesic medicines for adults with acute non-specific low back pain: systematic review and network meta-analysis
Michael A. Wewege(UNSW Sydney), James H. McAuley(UNSW Sydney), Christopher G. Maher(The University of Sydney), Matthew D. Jones(UNSW Sydney), Benedict M. Wand(The University of Notre Dame Australia), Andrew J. McLachlan(The University of Sydney), Saurab Sharma(UNSW Sydney), Rodrigo R N Rizzo(UNSW Sydney), Michael C Ferraro(The University of Sydney), Richard O. Day(St Vincent's Hospital Sydney), Siobhan M. Schabrun(Western University), Aidan G Cashin(New South Wales Department of Health), Sylvia M. Gustin(UNSW Sydney), Neil E O’Connell(Brunel University of London), Matthew K. Bagg, Adriani Nikolakopolou(University of Freiburg), Amanda D. Hagstrom(UNSW Sydney)
Cited by 58
Related Papers
What low back pain is and why we need to pay attention
|The Lancet|2018|4.7k
Prevention and treatment of low back pain: evidence, challenges, and promising directions
|The Lancet|2018|2.5k
Low back pain: a call for action
|The Lancet|2018|1.3k
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
|Journal of Clinical Epidemiology|2012|1.2k
Living systematic review: 1. Introduction—the why, what, when, and how
|Journal of Clinical Epidemiology|2017|676